Stage I Mantle Cell Lymphoma Terminated Phase 1 Trials for Rituximab (DB00073)

Also known as: Mantle cell lymphoma stage I

IndicationStatusPhase
DBCOND0029478 (Stage I Mantle Cell Lymphoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01045928Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin LymphomaTreatment